0001437749-14-003442.txt : 20140305 0001437749-14-003442.hdr.sgml : 20140305 20140305105658 ACCESSION NUMBER: 0001437749-14-003442 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140303 FILED AS OF DATE: 20140305 DATE AS OF CHANGE: 20140305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Altieri Richard M. CENTRAL INDEX KEY: 0001592351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 14667806 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC STREET 2: 94C INNOVATION DRIVE CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2014-03-03 0001586049 Oxford Immunotec Global PLC OXFD 0001592351 Altieri Richard M. C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Chief Financial Officer Ordinary Shares 2014-03-03 4 A 0 28720 0 A 28720 D SHARE OPTION (RIGHT TO BUY) 22.99 2014-03-03 4 A 0 28720 0 A 2024-03-03 Ordinary Shares 28720 28720 D Option granted under Issuer's 2013 Share Incentive Plan. Will become exercisable as to 1,795 shares on April 1, 2014 and will become exercisable as to the remainder ratably on the first day of each month from May 1, 2014 through January 1, 2018. /s/ Elizabeth M. Keiley, as Attorney-in-Fact 2014-03-05